SPRY

2.96011.90%
DC

Donn Casale

CEO, President & Director

Mr. Donn Casale serves as President at ARS Pharmaceuticals, Inc. since June 01, 2026 and is its CEO & Director since July 7, 2026. He was Chief Commercial Officer at Dynavax Technologies Corporation since 2023 until February 10, 2026 and also served Senior Vice President of Commercial until 2023. He is the Senior Vice President of Dynavax Technologies Corporation until February 10, 2026. He was Vice President of Sales and Marketing at Dynavax Technologies Corporation. He was responsible for developing and managing all aspects of US commercial including the go-to market strategy, brand P&L, marketing and sales execution to support the launch of HEPLISAV-B. Mr. Casale has more than 20 years of experience in the pharmaceutical industry, with over 12 of those years directly related to vaccines. Mr. Casale began his career in 2000 at Merck where he held a variety of positions with increasing responsibility in sales leadership, marketing and corporate strategy to support the launches of ZOSTAVAX®, GARDASIL®, ROTATEQ® and PROQUAD®. In addition to his experience at Merck, Mr. Casale spent 3 years at Depomed where he held management positions in marketing and sales operations. Mr. Casale earned a B.A degree in Political Science from California Polytechnic State University, San Luis Obispo.

Positions